NCT00398372 - Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma Patients Receiving Antibody Treatment | Biotech Hunter

Enrollment

500

Participants

Timeline

Start Date

November 30, 2000

Primary Completion Date

June 30, 2007

Study Completion Date

September 30, 2009

Conditions

Lymphoma, Non-HodgkinLymphomas: Non-HodgkinLymphomas: Non-Hodgkin Cutaneous LymphomaLymphomas: Non-Hodgkin Diffuse Large B-CellLymphomas: Non-Hodgkin Follicular / Indolent B-CellLymphomas: Non-Hodgkin Mantle CellLymphomas: Non-Hodgkin Marginal ZoneLymphomas: Non-Hodgkin Peripheral T-CellLymphomas: Non-Hodgkin Waldenstr Macroglobulinemia

Interventions

DRUG

Rituximab

DRUG

Epratuzumab

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford